IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE) — FDA Approval ANDA075111 (ACTAVIS MID ATLANTIC)
IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE) — FDA Approval ANDA075111 (ACTAVIS MID ATLANTIC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: IPRATROPIUM BROMIDE; Active ingredients: IPRATROPIUM BROMIDE; Application number: ANDA075111.
| Brand name | IPRATROPIUM BROMIDE |
|---|---|
| Active ingredients | IPRATROPIUM BROMIDE |
| Application number | ANDA075111 |
| Sponsor | ACTAVIS MID ATLANTIC |
| Dosage form | SOLUTION |
| Route | INHALATION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19990422 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →